MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$274,497K
Net loss
-$274,448K
Net unrealized
(loss) gain on...
-$49K
Loss from operations
-$269,404K
Total other (loss)
income, net
-$5,044K
Revenue
$36K
Interest income, net
$13,080K
Total operating
expenses
$269,440K
Other (expense)
income, net
-$18,124K
Other operating
income, net
$2,145K
Research and development
$158,675K
Acquired in-process
research and development
$66,332K
General and
administrative
$45,135K
Impairment of long-lived
assets
$1,443K
Back
Back
Income Statement
source: myfinsight.com
Lyell Immunopharma, Inc. (LYEL)
Lyell Immunopharma, Inc. (LYEL)